Drug production value share of antineoplastics Japan 2018, by category
The statistic shows the distribution of the drug production value of antineoplastics in Japan in 2018, broken down by sub therapeutic category. In 2018, the production value of antimetabolites made up the largest share with approximately five percent of the total production value, followed by antitumor plant extract preparations with almost around 2.5 percent.